GSK- Egypt hires Grant Thornton to prepare fair value study to consumer healthcare assets
Updated 7/29/2021 11:50:33 AM
ArabFinance: GlaxoSmithKline- Egypt (GSK- Egypt) hired Grant Thornton Mohamed Hilal to prepare the fair value study for consumer healthcare assets, according to filing to the Egyptian Exchange on July 29th.
GlaxoSmithKline, the UK-based company and the owner of GSK- Egypt, will establish a new company to market the consumer health products, while GlaxoSmithKline will manufacture and market pharmaceutical/vaccines.
The listed company distributed annual cash dividends of EGP 0.50 per share on July 7th.
GSK Egypt, a member of the British pharmaceutical company Glaxo Group, is an Egypt-based company engaged in the manufacture, packaging, marketing, sale, and distribution of pharmaceutical products.
